Related Experiment Video
Updated: Mar 17, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Childhood Epilepsy with Occipital Paroxysm: Classification, Atypical Evolution and Long-Term Prognosis in 35 Patients
Ayşe Aksoy1, Göknur Haliloğlu, Dilek Yalnızoğlu
1Department of Pediatrics, Hacettepe University Faculty of Medicine; Dr. Sami Ulus Children's Hospital, Ankara, Turkey. aysechild@gmail.com.
Insights
Childhood epilepsy with occipital paroxysms (CEOP) can present with atypical symptoms like vomiting and visual disturbances. Management should consider mixed clinical findings rather than strict age-based classifications.
Area of Science:
- Neurology
- Pediatric Neurology
Background:
- Childhood epilepsy with occipital paroxysms (CEOP) encompasses various syndromes with distinct clinical and EEG features.
- Understanding atypical presentations is crucial for accurate diagnosis and management of CEOP.
Purpose of the Study:
- To analyze the clinical and EEG characteristics of CEOP, focusing on atypical ictal symptoms, evolution, and outcomes.
- To evaluate the current classification of CEOP and its implications for patient management.
Main Methods:
- Retrospective study of 35 patients diagnosed with CEOP.
- Classification of patients into Panayiotopoulos syndrome, Gastaut syndrome, and mixed types.
- Detailed analysis of ictal symptoms, EEG findings, and patient evolution.
Main Results:
- Nine patients (25%) with mixed-type CEOP exhibited atypical ictal manifestations including vomiting, visual symptoms, eye deviation, and headaches.
- Five patients demonstrated atypical evolutionary patterns.
- The study suggests that strict delineation into early-onset or late-onset CEOP may be inappropriate due to mixed clinical findings across ages.
Conclusions:
- CEOP can present with significant atypical symptoms and evolutionary patterns, particularly in mixed types.
- A flexible approach to CEOP classification, considering mixed clinical findings irrespective of age, is recommended.
- Further investigation into the reasons behind atypical CEOP presentations and age-related evolution is warranted.
Abstract:
We studied childhood epilepsy with occipital paroxysms (CEOP) with regard to typical and/or atypical ictal symptoms, EEG findings, as well as atypical evolution and outcome. This report focuses on the main clinical and EEG features of CEOP underlying its atypical symptoms and its management. Thirty-five patients with CEOP were subdivided into Panayiotopoulos syndrome (n=15), Gastaut syndrome (n=11), and mixed type (n=9). Nine patients (25%) with CEOP (mixed type) had shown atypical ictal manifestations and presented combinations of vomiting (100%) along with visual symptoms (66%), and/or eye deviation (66%), and headaches (44%). Five patients with CEOP had atypical evolution. However, the dictate for strict delineation into either the early-onset or late-onset forms of CEOP should be discarded because many children will present mixed clinical findings at varying ages. We think a detailed evaluation should be carried out as to why certain patients who apply have atypical findings, and whether each patient has age related evolution or not.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
06:04Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...